A carregar...

Prevention of Autoimmune Diabetes by Ectopic Pancreatic β-Cell Expression of Interleukin-35

Interleukin (IL)-35 is a newly identified inhibitory cytokine used by T regulatory cells to control T cell–driven immune responses. However, the therapeutic potential of native, biologically active IL-35 has not been fully examined. Expression of the heterodimeric IL-35 cytokine was targeted to β-ce...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Bettini, Maria, Castellaw, Ashley H., Lennon, Greig P., Burton, Amanda R., Vignali, Dario A.A.
Formato: Artigo
Idioma:Inglês
Publicado em: American Diabetes Association 2012
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3357277/
https://ncbi.nlm.nih.gov/pubmed/22427377
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2337/db11-0784
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!